IT1395907B1 - Derivato ftalocianinico costituito da una miscela di quattro isomeri - Google Patents

Derivato ftalocianinico costituito da una miscela di quattro isomeri

Info

Publication number
IT1395907B1
IT1395907B1 ITFI2009A000168A ITFI20090168A IT1395907B1 IT 1395907 B1 IT1395907 B1 IT 1395907B1 IT FI2009A000168 A ITFI2009A000168 A IT FI2009A000168A IT FI20090168 A ITFI20090168 A IT FI20090168A IT 1395907 B1 IT1395907 B1 IT 1395907B1
Authority
IT
Italy
Prior art keywords
ftalocyanic
isomers
mixture
derivative consisting
derivative
Prior art date
Application number
ITFI2009A000168A
Other languages
English (en)
Inventor
Donata Dei
Gabrio Roncucci
Giacomo Chiti
Daniele Nistri
Original Assignee
Molteni E C Dei Flii Alitti Societa Di Esercizio Spa L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ITFI2009A000168A priority Critical patent/IT1395907B1/it
Application filed by Molteni E C Dei Flii Alitti Societa Di Esercizio Spa L filed Critical Molteni E C Dei Flii Alitti Societa Di Esercizio Spa L
Priority to PT107713463T priority patent/PT2459567E/pt
Priority to DK10771346.3T priority patent/DK2459567T3/en
Priority to MX2012000857A priority patent/MX2012000857A/es
Priority to US13/387,407 priority patent/US20120135972A1/en
Priority to CA2769161A priority patent/CA2769161C/en
Priority to SI201031087T priority patent/SI2459567T1/sl
Priority to PL10771346T priority patent/PL2459567T3/pl
Priority to AU2010277539A priority patent/AU2010277539B2/en
Priority to BR112012002127-3A priority patent/BR112012002127B1/pt
Priority to CN201080033193.0A priority patent/CN102482288B/zh
Priority to EP10771346.3A priority patent/EP2459567B1/en
Priority to ES10771346.3T priority patent/ES2557554T3/es
Priority to PCT/EP2010/061112 priority patent/WO2011012698A2/en
Priority to NZ598362A priority patent/NZ598362A/xx
Priority to JP2012522179A priority patent/JP5819297B2/ja
Priority to KR1020127003398A priority patent/KR20130045832A/ko
Priority to HUE10771346A priority patent/HUE028221T2/en
Publication of ITFI20090168A1 publication Critical patent/ITFI20090168A1/it
Priority to IL217733A priority patent/IL217733A/en
Publication of IT1395907B1 publication Critical patent/IT1395907B1/it
Application granted granted Critical
Priority to US15/008,875 priority patent/US10730890B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/06Zinc compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITFI2009A000168A 2009-07-30 2009-07-30 Derivato ftalocianinico costituito da una miscela di quattro isomeri IT1395907B1 (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
ITFI2009A000168A IT1395907B1 (it) 2009-07-30 2009-07-30 Derivato ftalocianinico costituito da una miscela di quattro isomeri
ES10771346.3T ES2557554T3 (es) 2009-07-30 2010-07-30 Derivado de ftalocianina que consiste en una mezcla de 4 isómeros
DK10771346.3T DK2459567T3 (en) 2009-07-30 2010-07-30 PHTHALOCYANIN DERIVATIVE CONSISTS OF A MIXTURE OF 4 ISOMERS
US13/387,407 US20120135972A1 (en) 2009-07-30 2010-07-30 Phthalocyanine derivative consisting of a mixture of 4 isomers
CA2769161A CA2769161C (en) 2009-07-30 2010-07-30 Phthalocyanine derivative consisting of a mixture of 4 isomers
SI201031087T SI2459567T1 (sl) 2009-07-30 2010-07-30 Derivat ftalocianina, sestoječ iz zmesi 4 izomerov
PL10771346T PL2459567T3 (pl) 2009-07-30 2010-07-30 Pochodne ftalocyjaniny zawierające mieszaninę 4 izomerów
AU2010277539A AU2010277539B2 (en) 2009-07-30 2010-07-30 Phthalocyanine derivative consisting of a mixture of 4 isomers
PCT/EP2010/061112 WO2011012698A2 (en) 2009-07-30 2010-07-30 Phthalocyanine derivative consisting of a mixture of 4 isomers
CN201080033193.0A CN102482288B (zh) 2009-07-30 2010-07-30 由4种同分异构体的混合物组成的酞菁衍生物
PT107713463T PT2459567E (pt) 2009-07-30 2010-07-30 Derivado de ftalocianina consistindo numa mistura de 4 isómeros
MX2012000857A MX2012000857A (es) 2009-07-30 2010-07-30 Derivado de ftalocianina que consiste de una mezcla de 4 isomeros.
BR112012002127-3A BR112012002127B1 (pt) 2009-07-30 2010-07-30 Derivado de ftalocianina consistindo em uma mistura de 4 isômeros
NZ598362A NZ598362A (en) 2009-07-30 2010-07-30 Phthalocyanine derivative consisting of a mixture of 4 isomers
JP2012522179A JP5819297B2 (ja) 2009-07-30 2010-07-30 4種類の異性体の混合物からなるフタロシアニン誘導体混合物の調整方法
KR1020127003398A KR20130045832A (ko) 2009-07-30 2010-07-30 4종 이성질체의 혼합물로 이루어진 프탈로시아닌 유도체
HUE10771346A HUE028221T2 (en) 2009-07-30 2010-07-30 A phthalocyanine derivative consisting of a mixture of 4 isomers
EP10771346.3A EP2459567B1 (en) 2009-07-30 2010-07-30 Phthalocyanine derivative consisting of a mixture of 4 isomers
IL217733A IL217733A (en) 2009-07-30 2012-01-25 Patalocyanine derivatives containing a mixture of four isomers
US15/008,875 US10730890B2 (en) 2009-07-30 2016-01-28 Phthalocyanine derivative consisting of a mixture of 4 isomers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI2009A000168A IT1395907B1 (it) 2009-07-30 2009-07-30 Derivato ftalocianinico costituito da una miscela di quattro isomeri

Publications (2)

Publication Number Publication Date
ITFI20090168A1 ITFI20090168A1 (it) 2011-01-31
IT1395907B1 true IT1395907B1 (it) 2012-11-02

Family

ID=41822411

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI2009A000168A IT1395907B1 (it) 2009-07-30 2009-07-30 Derivato ftalocianinico costituito da una miscela di quattro isomeri

Country Status (19)

Country Link
US (2) US20120135972A1 (it)
EP (1) EP2459567B1 (it)
JP (1) JP5819297B2 (it)
KR (1) KR20130045832A (it)
CN (1) CN102482288B (it)
AU (1) AU2010277539B2 (it)
BR (1) BR112012002127B1 (it)
CA (1) CA2769161C (it)
DK (1) DK2459567T3 (it)
ES (1) ES2557554T3 (it)
HU (1) HUE028221T2 (it)
IL (1) IL217733A (it)
IT (1) IT1395907B1 (it)
MX (1) MX2012000857A (it)
NZ (1) NZ598362A (it)
PL (1) PL2459567T3 (it)
PT (1) PT2459567E (it)
SI (1) SI2459567T1 (it)
WO (1) WO2011012698A2 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102357352B1 (ko) * 2020-01-06 2022-01-28 이화여자대학교 산학협력단 화합물, 상기 화합물을 포함하는 조성물, 상기 화합물을 이용하여 박테리아 세균을 비활성화 또는 사멸시키는 방법
WO2023241950A1 (en) 2022-06-13 2023-12-21 Basf Se Mixtures of compounds having improved solubility for use as markers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1294325B1 (it) 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
JP4560812B2 (ja) 2001-10-29 2010-10-13 エル.モルテニ アンド シー.デイ フラテッリ アリッチ ソシエタ’ディ エセルチヅィオ ソシエタ ペル アチオニ 金属フタロシアニンの部位異性体の分離
ITFI20050093A1 (it) * 2005-05-05 2006-11-06 Molteni & C Processo per la preparazione di cloruri di derivati ftalocianinici comprendenti almeno un gruppo ammonio quaternario
ITFI20050092A1 (it) * 2005-05-05 2006-11-06 Molteni & C Derivati ftalocianinici, processo per la loro preparazione, composizioni farmaceutiche che li contengono e loro uso
CN101212987B (zh) * 2005-06-29 2011-02-02 阿利提兄弟有限公司L.莫太尼公司 自杀菌产品
EP1904060B1 (en) * 2005-06-29 2011-06-01 L. Molteni & C. Dei Fratelli Alitti Societa' Di Esercizio Societa' Per Azioni Use of phthalocyanine derivates for the non-photodynamic treatment of diseases

Also Published As

Publication number Publication date
EP2459567B1 (en) 2015-09-30
HUE028221T2 (en) 2016-12-28
ITFI20090168A1 (it) 2011-01-31
US20170073358A1 (en) 2017-03-16
NZ598362A (en) 2013-04-26
AU2010277539A1 (en) 2012-03-15
EP2459567A2 (en) 2012-06-06
SI2459567T1 (sl) 2016-02-29
JP5819297B2 (ja) 2015-11-24
WO2011012698A3 (en) 2011-03-31
BR112012002127B1 (pt) 2021-08-31
MX2012000857A (es) 2012-06-01
CN102482288B (zh) 2015-05-13
WO2011012698A2 (en) 2011-02-03
ES2557554T3 (es) 2016-01-27
CA2769161A1 (en) 2011-02-03
DK2459567T3 (en) 2016-01-11
CA2769161C (en) 2019-05-28
IL217733A0 (en) 2012-03-29
PT2459567E (pt) 2016-01-22
IL217733A (en) 2016-04-21
CN102482288A (zh) 2012-05-30
AU2010277539B2 (en) 2014-02-20
PL2459567T3 (pl) 2016-02-29
KR20130045832A (ko) 2013-05-06
US20120135972A1 (en) 2012-05-31
JP2013500312A (ja) 2013-01-07
US10730890B2 (en) 2020-08-04
BR112012002127A2 (pt) 2016-08-09

Similar Documents

Publication Publication Date Title
CO6990725A2 (es) Composiciones blanqueadoras para el cuidado oral
DK2421825T3 (da) Azetidinyldiamider som monoacylglycerollipase-inhibitorer
DK2899191T3 (da) Oxazol-substituerede indazoler som pi3-kinaseinhibitorer
DK2364293T3 (da) Hidtil ukendte pyrazol-4-N-alkoxycarboxamider som mikrobiocider
DK2395834T3 (da) Natriumnitrit-holdige farmaceutiske sammensætninger
BR112013027985A2 (pt) kit de higiene oral para exibição de uma porção de uma escova de dente
CO6880062A2 (es) Formulación de una cápsula que comprende montelukasty levocetirizina
DK3159329T3 (da) Anvendelse af 2-hidroxyderivater af polyumættede fedtsyrer som medikamenter
SMT201500268B (it) Derivato di 5-idrossipirimidin-4-carbossammide
SMT201600076B (it) Derivati di 2-osso-1-pirrolidinil imidazotiadiazolo
DK3070091T3 (da) Benzodioxolderivater som phosphodiesterasehæmmere
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
CO6862143A2 (es) Procedimiento para el refuerzo de una unidad de construcción
BRPI0918134A2 (pt) derivado de prostaglandina i2
BR112013019061A2 (pt) composto inibidor da caspase-2, composição farmacêutica e uso de um composto
IT1395907B1 (it) Derivato ftalocianinico costituito da una miscela di quattro isomeri
SMT201500178B (it) Inibitori di nf-kb
BR112012015370A2 (pt) artigo higiênico
IT1394268B1 (it) Procedimento per la realizzazione di una calzatura
FR2948536B1 (fr) Composition desinfectante
CO6821962A2 (es) Composiciones para el cuidado oral
ES1071954Y (es) Una funda higienica
ITPD20090106A1 (it) Leggio per luoghi di culto
FI20100331A0 (fi) WC-istuin
FI20090425A0 (fi) WC-istuin